Eric R. Fearon
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics 22
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies 23
- Cancer-related Molecular Pathways 17
- Pathology and Forensic Medicine top 0.01%
- Genetic factors in colorectal cancer 55
- Molecular Biology top 0.05%
- Wnt/β-catenin signaling in development and cancer 46
- Cancer-related gene regulation 38
- Kruppel-like factors research 15
- Biotechnology top 0.1%
-
- Ovarian cancer diagnosis and treatment 14
- Co-authors
- Bert VogelsteinStanley R. HamiltonScott E. KernKathleen R. ChoJohannes L. BosAlida M.M. SmitsMark LeppertSuzanne J. Baker
- Partner nations
- United StatesJapanPoland
In The Last Decade
Eric R. Fearon
190 papers receiving 44.7k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 12.5k
- Oncology 20.8k
- Pathology and Forensic Medicine 13.0k
- Molecular Biology 23.8k
- Biotechnology 1.9k
Countries citing papers authored by Eric R. Fearon
This map shows the geographic impact of Eric R. Fearon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Fearon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Fearon more than expected).
Fields of papers citing papers by Eric R. Fearon
This network shows the impact of papers produced by Eric R. Fearon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Fearon. The network helps show where Eric R. Fearon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric R. Fearon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 27 | |
| 3 | Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balancebreakdown → | 2021 | 188 |
| 4 | 2019 | 17 | |
| 5 | 2017 | 62 | |
| 6 | 2016 | 65 | |
| 7 | 2011 | 60 | |
| 8 | 2011 | 64 | |
| 9 | 2011 | 99 | |
| 10 | 2010 | 34 | |
| 11 | 2010 | 103 | |
| 12 | 2009 | 46 | |
| 13 | 2007 | 203 | |
| 14 | 2004 | 49 | |
| 15 | 2003 | 48 | |
| 16 | 2002 | 88 | |
| 17 | Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. | 2002 | 348 |
| 18 | 2002 | 51 | |
| 19 | Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. | 1995 | 119 |
| 20 | 1991 | 52 |
About Eric R. Fearon
Eric R. Fearon is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 191 papers that have together received 45.9k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (55 papers), Wnt/β-catenin signaling in development and cancer (46 papers), Cancer-related gene regulation (38 papers), Colorectal Cancer Treatments and Studies (23 papers), Cancer Genomics and Diagnostics (22 papers), Cancer-related Molecular Pathways (17 papers), Kruppel-like factors research (15 papers) and Ovarian cancer diagnosis and treatment (14 papers). The work is most often cited by research in Cancer Research (12.5k citations), Oncology (20.8k citations) and Pathology and Forensic Medicine (13.0k citations). Eric R. Fearon has collaborated with scholars based in United States, Japan and Poland. Frequent co-authors include Bert Vogelstein, Stanley R. Hamilton, Scott E. Kern, Kathleen R. Cho, Johannes L. Bos, Alida M.M. Smits, Mark Leppert, Suzanne J. Baker, Karen M. Hajra and Janice Nigro. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.